Quelling the discomfort of atopic dermatitis, the most common form of eczema, can be a daily quest. This inflamed, itchy skin condition can interfere with sleeping, socializing, and many other ...

Arcutis Biotherapeutics’ topical cream has racked up a second phase 3 win in eczema patients, putting the company on track to file for FDA approval in the indication in the second half of next year.

If you or someone you love has eczema, you know treating it can be frustrating. It takes a lot of trial and error to f ...

A clinical trial is underway testing a new kind of eczema treatment, developed to silence certain genes that play a role in skin inflammation. The results of a preclinical study were recently ...

Michelle Sansiveri's eczema began as a teenager with a tiny patch on her neck. A dermatologist prescribed the now 28-year-old a low-to-medium dose topical steroid cream with just one instruction: use ...

Leo Pharma has begun a phase 3 clinical trial of its topical pan-JAK inhibitor. The study will assess the ability of delgocitinib cream to improve outcomes in patients with moderate to severe chronic ...

On July 9, the US Food and Drug Administration approved the supplemental new drug application for roflumilast cream 0.15% for the treatment of mild to moderate atopic dermatitis (AD) in adults and in ...

LOS ANGELES — Crisaborole, a topical phosphodiesterase 4 inhibitor, improved the symptoms of mild to moderate eczema in two phase 3 safety and efficacy trials. This new drug, if approved, could be ...

Don't miss out on the headlines from Conditions. Followed categories will be added to My News. Steroid creams were my normal go-to and sometimes oral steroids too. I never questioned it. No one ever ...

Bethany said her symptoms have made her feel 'lonely' and 'isolated' (Collect/PA Real Life) A 20-year-old student says she would "do anything" to have her childhood eczema back after a suspected ...